Other
Gain on litigation settlement
Roivant Sciences Gain on litigation settlement remained flat by 0.0% to $192.56M in Q1 2026 compared to the prior quarter.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2025May 20, 2026
How to read this metric
An increase indicates a non-operating windfall, while a decrease suggests the absence of such settlements in the current period.
Detailed definition
This metric represents non-recurring income recognized from the successful resolution of legal disputes or settlements....
Peer comparison
Commonly reported by biopharma companies involved in intellectual property or patent litigation, often categorized under other income or non-operating gains.
Metric ID:
other_litigation_settlement_gainHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | $770.24M |
Range$0.00 – $770.24M
Gain on litigation settlement at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's gain on litigation settlement?
- Roivant Sciences (ROIV) reported gain on litigation settlement of $192.56M in Q1 2026.
- What does gain on litigation settlement mean?
- One-time income received from winning or settling a legal lawsuit.